Stockscreener 앱 받기
1.55
7.19%
-0.12
Vivos Therapeutics Inc 주식(VVOS)의 최신 뉴스
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - TipRanks
Vivos Therapeutics Appoints Gregg C. E. Johnson to Board of Directors - TradingView
Vivos Therapeutics, Inc. Appoints Gregg C. E. Johnson as Independent Director of the Board and Compensation Committee of the Board, Effective February 4, 2026 - marketscreener.com
Vivos Therapeutics to Distribute SoundHealth’s FDA-Cleared Sonu and Spatial Sleep Bands - HIT Consultant
Buyout Rumor: Will Vivos Therapeutics Inc benefit from government policyJuly 2025 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vivos Therapeutics and SoundHealth collaborate to expand access to groundbreaking FDA-cleared allergy and sleep technologies - marketscreener.com
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies - The Manila Times
Vivos Therapeutics Collaborates with SoundHealth to Enhance Airway and Sleep Health Solutions - Quiver Quantitative
Sound-based allergy and sleep bands join Vivos dentist network - Stock Titan
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Eagle-Tribune
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $4.92 Consensus PT from Brokerages - Defense World
Treasury Yields: Is Vivos Therapeutics Inc part of any ETFQuarterly Market Review & Expert Approved Momentum Ideas - baoquankhu1.vn
Aug Catalysts: Is Vivos Therapeutics Inc showing insider buyingNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offer2025 AllTime Highs & Verified Stock Trade Ideas - mfd.ru
Income Plays: What is the PEG ratio of CHSCNMarket Risk Analysis & Reliable Price Breakout Alerts - baoquankhu1.vn
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M - intellectia.ai
Vivos Therapeutics, Inc. Closes Exercise of Warrants Raising Approximately $4.64 Million for Working Capital - Quiver Quantitative
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Vivos Therapeutics Completes Warrant Inducement Financing Transaction - TipRanks
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Chipmakers Recap: What is the dividend yield of Vivos Therapeutics IncAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Vivos Announces Warrant Exercise Agreement - Dentistry Today
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds - MSN
Vivos Therapeutics announces $4.64 million warrant exercise deal By Investing.com - Investing.com Nigeria
Vivos Therapeutics Secures Convertible Bridge Financing Facility - TipRanks
Vivos Therapeutics Signs Convertible Note Agreement With V-Co Investors 3 - TradingView
Vivos Therapeutics announces $4.64 million warrant exercise deal - Investing.com India
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding - Intellectia AI
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos secures $4.64M from warrant exercise - Stock Titan
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Aug Summary: Is Vivos Therapeutics Inc part of any ETF2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS) - The Globe and Mail
Is Vivos Therapeutics Inc. stock a safe buy before earningsWeekly Stock Report & Long Hold Capital Preservation Tips - Улправда
Is Vivos Therapeutics Inc. stock a buy in volatile markets2025 Price Momentum & Weekly Stock Breakout Alerts - ulpravda.ru
Why analysts remain bullish on Vivos Therapeutics Inc. stockJuly 2025 Review & Safe Swing Trade Setup Alerts - Улправда
Can Vivos Therapeutics Inc. stock weather global recessionJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
Published on: 2026-01-08 23:11:17 - Улправда
Aug Update: Can Vivos Therapeutics Inc. stock weather global recessionPortfolio Profit Report & Fast Gaining Stock Reports - ulpravda.ru
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
How Vivos Therapeutics Inc. stock compares to industry benchmarksUtilities Sector Analysis & See Risk Factors Before Making Any Move - Улправда
Vivos Therapeutics (VVOS) upgraded to buy: Here's what you should know - MSN
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Is Vivos Therapeutics Inc a good long term investmentProtective Put Strategies & Ride the Trends That Billionaires Follow - earlytimes.in
Vivos Therapeutics (NASDAQ:VVOS) Trading Up 24.6% – What’s Next? - Defense World
Aug Breakouts: Why retail investors favor Vivos Therapeutics Inc stock2025 AllTime Highs & Capital Protection Trade Alerts - moha.gov.vn
VVOS SEC FilingsVivos Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vivos Inc Summarizes Progress in its Animal Therapy Division - GlobeNewswire
Cancer-fighting pet therapy soars 1,200% as more vets join in 2025 - Stock Titan
0.45%
0.31%
자본화:
|
볼륨(24시간):